标题
Recent advances in antibody‐based immunotherapy strategies for COVID‐19
作者
关键词
-
出版物
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-06-23
DOI
10.1002/jcb.30017
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID-19 vaccines: where we stand and challenges ahead
- (2021) Guido Forni et al. CELL DEATH AND DIFFERENTIATION
- Passive immunization and its rebirth in the era of the COVID-19 pandemic
- (2021) Charles S. Pavia et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- CAR T cells in solid tumors: challenges and opportunities
- (2021) Faroogh Marofi et al. Stem Cell Research & Therapy
- COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods
- (2021) Faroogh Marofi et al. Anti-Cancer Agents in Medicinal Chemistry
- Bamlanivimab for treatment of COVID‐19 in solid organ transplant recipients: Early single‐center experience
- (2021) Abhay Dhand et al. CLINICAL TRANSPLANTATION
- Efficacy and tolerability of bevacizumab in patients with severe Covid-19
- (2021) Jiaojiao Pang et al. Nature Communications
- Effectiveness of convalescent plasma in Indian patients with COVID-19
- (2021) Sandeep Budhiraja et al. BLOOD CELLS MOLECULES AND DISEASES
- SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
- (2021) Markus Hoffmann et al. CELL
- IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
- (2021) Michal A. Stanczak et al. Nature Communications
- Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
- (2021) Safa Tahmasebi et al. LIFE SCIENCES
- Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
- (2021) Mahnaz Ghaebi et al. LIFE SCIENCES
- Presumed Asymptomatic Carrier Transmission of COVID-19
- (2020) Yan Bai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Reducing mortality from 2019-nCoV: host-directed therapies should be an option
- (2020) Alimuddin Zumla et al. LANCET
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
- (2020) Jasper Fuk-Woo Chan et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Convalescent plasma as a potential therapy for COVID-19
- (2020) Long Chen et al. LANCET INFECTIOUS DISEASES
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
- (2020) Camilla Rothe et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement
- (2020) Kunling Shen et al. World Journal of Pediatrics
- Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
- (2020) Xiaolong Tian et al. Emerging Microbes & Infections
- Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
- (2020) Jasper Fuk-Woo Chan et al. Emerging Microbes & Infections
- Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review
- (2020) Junxiong Pang et al. Journal of Clinical Medicine
- What is the true incidence of COVID-19 in patients with rheumatic diseases?
- (2020) Ennio Giulio Favalli et al. ANNALS OF THE RHEUMATIC DISEASES
- A potential role for integrins in host cell entry by SARS-CoV-2
- (2020) Christian JA Sigrist et al. ANTIVIRAL RESEARCH
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily
- (2020) Eleni Gavriilaki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
- (2020) Daniel Wrapp et al. CELL
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
- (2020) Courtney M. Campbell et al. CIRCULATION
- Practical aspects of targeting IL-6 in COVID-19 disease
- (2020) Cassandra Calabrese et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- Antibody Detection and Dynamic Characteristics in Patients with COVID-19
- (2020) Fei Xiang et al. CLINICAL INFECTIOUS DISEASES
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Non‐complicated evolution of COVID ‐19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab
- (2020) M. Valenti et al. Dermatologic Therapy
- Covid-19 infection in Crohn’s disease under treatment with adalimumab
- (2020) Antonio Tursi et al. GUT
- Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
- (2020) José-María Díez et al. Immunotherapy
- Convalescent Plasma to Treat COVID-19
- (2020) John D. Roback et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
- (2020) Chenguang Shen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
- (2020) Safa Tahmasebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Complementopathies and precision medicine
- (2020) Eleni Gavriilaki et al. JOURNAL OF CLINICAL INVESTIGATION
- The convalescent sera option for containing COVID-19
- (2020) Arturo Casadevall et al. JOURNAL OF CLINICAL INVESTIGATION
- Laboratory Diagnosis of COVID-19: Current Issues and Challenges
- (2020) Yi-Wei Tang et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
- (2020) Yu-Lin Lee et al. JOURNAL OF INFECTION
- Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19
- (2020) Yun Xie et al. JOURNAL OF INFECTION
- Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19
- (2020) Zeming Liu et al. JOURNAL OF INFECTION
- Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
- (2020) Qing-Lei Zeng et al. JOURNAL OF INFECTIOUS DISEASES
- SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression
- (2020) Ilaria Tresoldi et al. JOURNAL OF MEDICAL VIROLOGY
- Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
- (2020) Mingxiang Ye et al. JOURNAL OF MEDICAL VIROLOGY
- Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab
- (2020) Michael T. Dolinger et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Evolution of COVID‐19 infection in 4 psoriatic patients treated with biological drugs
- (2020) A. Conti et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Why tocilizumab could be an effective treatment for severe COVID-19?
- (2020) Binqing Fu et al. Journal of Translational Medicine
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients
- (2020) T. Klopfenstein et al. MEDECINE ET MALADIES INFECTIEUSES
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic
- (2020) Wallace Brownlee et al. NEUROLOGY
- Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
- (2020) Franco Locatelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of convalescent plasma therapy in severe COVID-19 patients
- (2020) Kai Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
- (2020) Barry Rockx et al. SCIENCE
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
- (2020) Giuseppe Magro Travel Medicine and Infectious Disease
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
- (2020) Alfonso J. Rodriguez-Morales et al. Travel Medicine and Infectious Disease
- Coronavirus disease 2019 (COVID-19): A literature review
- (2020) Harapan Harapan et al. Journal of Infection and Public Health
- Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
- (2020) Ruklanthi de Alwis et al. EBioMedicine
- High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- (2020) Wei Cao et al. Open Forum Infectious Diseases
- Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
- (2020) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- Potential role of IL‐17 blocking agents in the treatment of severe COVID‐19?
- (2020) Vedrana Bulat et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
- (2020) Ahmed O. Hassan et al. CELL
- Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
- (2020) Jiandong Huo et al. Cell Host & Microbe
- COVID-19: Immunology and treatment options
- (2020) Susanna Felsenstein et al. CLINICAL IMMUNOLOGY
- COVID ‐19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain
- (2020) Rubén Queiro Silva et al. Dermatologic Therapy
- Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications
- (2020) Subramanian Loganathan et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation
- (2020) Emilie Seydoux et al. IMMUNITY
- Case report: use of lenzilumab and tocilizumab for the treatment of coronavirus disease 2019
- (2020) Megan Melody et al. Immunotherapy
- Identification of an anti-SARS-CoV-2 receptor binding domain directed human monoclonal antibody from a naïve semi-synthetic library
- (2020) Hilal Ahmed Parray et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Early safety indicators of COVID-19 convalescent plasma in 5000 patients
- (2020) Michael J. Joyner et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunomodulatory Therapeutic Proteins in COVID‐19: Current Clinical Development and Clinical Pharmacology Considerations
- (2020) Ping Ji et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Impact of COVID‐19 outbreak on the care of patients with inflammatory bowel disease: a comparison before and after the outbreak in South China
- (2020) Ying‐Fan Zhang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
- (2020) Michael J. Joyner et al. MAYO CLINIC PROCEEDINGS
- Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
- (2020) Jiangdong Huo et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Treatment for emerging viruses: Convalescent plasma and COVID-19
- (2020) Bethany L. Brown et al. TRANSFUSION AND APHERESIS SCIENCE
- Successful Treatment of Severe COVID-19 Pneumonia With Clazakizumab in a Heart Transplant Recipient: A Case Report
- (2020) Gaurang Vaidya et al. TRANSPLANTATION PROCEEDINGS
- ACCORD: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform Study to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalised Patients: A structured summary of a study protocol for a randomised controlled trial
- (2020) Tom Wilkinson et al. Trials
- On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
- (2020) Carolina Corrêa Giron et al. VIRUS RESEARCH
- Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
- (2020) Amin Sedokani et al. Drug Design Development and Therapy
- SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
- (2020) Kuldeep Dhama et al. Travel Medicine and Infectious Disease
- Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
- (2020) Tomás Palanques-Pastor et al. European Journal of Hospital Pharmacy-Science and Practice
- Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
- (2020) Puja Mehta et al. Lancet Respiratory Medicine
- Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
- (2020) Aldo Bonaventura et al. Frontiers in Immunology
- Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
- (2020) Vincenzo Montesarchio et al. Journal for ImmunoTherapy of Cancer
- Coronavirus Pandemic—Therapy and Vaccines
- (2020) Kenneth Lundstrom Biomedicines
- Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)
- (2020) Calvin C Sheng et al. CLINICAL CARDIOLOGY
- Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
- (2020) Jeffrey Laurence et al. CLINICAL IMMUNOLOGY
- Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
- (2020) Armin Sadeghi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
- (2020) Julia Schwaiger et al. JOURNAL OF INFECTIOUS DISEASES
- GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Control Study
- (2020) Zelalem Temesgen et al. MAYO CLINIC PROCEEDINGS
- The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
- (2020) Maja Buszko et al. NATURE IMMUNOLOGY
- Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
- (2020) Kaewta Rattanapisit et al. Scientific Reports
- Convalescent Plasma: A Challenging Tool to Treat COVID-19 Patients—A Lesson from the Past and New Perspectives
- (2020) Valeria Selvi Biomed Research International
- Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
- (2020) Massimo Caracciolo et al. Frontiers in Immunology
- Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (2020) Wen Shi Lee et al. Nature Microbiology
- Can Immunization of Hens Provide Oral-Based Therapeutics against COVID-19?
- (2020) José M. Pérez de la Lastra et al. Vaccines
- Formation and Maturation of the Phagosome: A Key Mechanism in Innate Immunity against Intracellular Bacterial Infection
- (2020) Hyo-Ji Lee et al. Microorganisms
- Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID‐19 patients
- (2020) Safa Tahmasebi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
- (2020) Ventura A. Simonovich et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
- (2020) Peter Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emapalumab: First Global Approval
- (2019) Zaina T. Al-Salama DRUGS
- Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial
- (2019) Farsad Eskandary et al. Trials
- Recent Advances targeting CCR5 for Cancer and its Role in Immuno-Oncology
- (2019) Xuanmao Jiao et al. CANCER RESEARCH
- Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis
- (2019) Chiara Crotti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
- (2019) Krishnansu S. Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- GM-CSF in inflammation
- (2019) John A. Hamilton JOURNAL OF EXPERIMENTAL MEDICINE
- Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
- (2019) Abdolreza Esmaeilzadeh et al. BIOMEDICINE & PHARMACOTHERAPY
- A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)
- (2019) Timothy F Cloughesy et al. NEURO-ONCOLOGY
- Monoclonal Antibody Therapy for Ebola Virus Disease
- (2019) Myron M. Levine NEW ENGLAND JOURNAL OF MEDICINE
- Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
- (2018) Jae-Hoon Ko et al. ANTIVIRAL THERAPY
- FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome
- (2018) Robert Q. Le et al. ONCOLOGIST
- Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody
- (2018) Gerd R. Burmester et al. Arthritis & Rheumatology
- GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
- (2018) Rosalie M. Sterner et al. BLOOD
- Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis
- (2018) Xiang Guo et al. International Journal of Rheumatic Diseases
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
- (2018) Lisa E. Gralinski et al. mBio
- Canakinumab for the treatment of familial Mediterranean fever
- (2017) Huri Ozdogan et al. Expert Review of Clinical Immunology
- IVIG-mediated effector functions in autoimmune and inflammatory diseases
- (2017) Caroline Galeotti et al. INTERNATIONAL IMMUNOLOGY
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis
- (2017) Xiang Guo et al. RHEUMATOLOGY
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate-to-severe plaque psoriasis
- (2016) K. Reich et al. BRITISH JOURNAL OF DERMATOLOGY
- Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy
- (2016) Fang Chen et al. JOURNAL OF IMMUNOLOGICAL METHODS
- IL-6 Trans-Signaling Drives Murine Crescentic GN
- (2015) G. S. Braun et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform
- (2015) Alex Klarenbeek et al. mAbs
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Yaseen M. Arabi et al. ANNALS OF INTERNAL MEDICINE
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
- (2014) John Mair-Jenkins et al. JOURNAL OF INFECTIOUS DISEASES
- Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
- (2014) Frits van Rhee et al. LANCET ONCOLOGY
- Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums
- (2013) Geraldine Navarro et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Adverse Effects of Human Immunoglobulin Therapy
- (2013) E. Richard Stiehm TRANSFUSION MEDICINE REVIEWS
- CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction
- (2010) P. Nair et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Escape from Human Monoclonal Antibody Neutralization Affects In Vitro and In Vivo Fitness of Severe Acute Respiratory Syndrome Coronavirus
- (2010) Barry Rockx et al. JOURNAL OF INFECTIOUS DISEASES
- Bevacizumab (Avastin)
- (2009) S.K. Mukherji AMERICAN JOURNAL OF NEURORADIOLOGY
- General Strategy to Humanize a Camelid Single-domain Antibody and Identification of a Universal Humanized Nanobody Scaffold
- (2008) Cécile Vincke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge
- (2008) B. Rockx et al. JOURNAL OF VIROLOGY
- Single-domain antibody fragments with high conformational stability
- (2002) Mireille Dumoulin et al. PROTEIN SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now